The NIH Roadmap: Re-Engineering the Clinical Research Enterprise
|
|
- Alyson Brooks
- 4 years ago
- Views:
Transcription
1 NIH BACKGROUNDER National Institutes of Health The NIH Roadmap: Re-Engineering the Clinical Research Enterprise Clinical research is the linchpin of the nation s biomedical research enterprise. Before a therapy is approved for general use, it must be studied carefully in the laboratory to understand its mechanism of action, effectiveness, and potential risks. The safety and benefits of the therapy for humans are then proven through an orderly series of tests in people. While clinical research helps ensure that new products and techniques that ultimately are made available to doctors and their patients are safe and effective, it is a lengthy and sometimes inefficient process. To accelerate and strengthen the clinical research process, this set of NIH Roadmap initiatives will re-engineer the clinical research enterprise by adopting a systematic infrastructure that will better serve the evolving field of scientific discovery. This effort, which complements the other initiatives that comprise the NIH Roadmap, will provide the necessary foundation for advancing basic and clinical research. With the NIH Roadmap in action, investigators will be better poised to translate basic discoveries into the reality of better health for our nation. Although biomedical research has succeeded in converting many diseases once considered uniformly lethal into more chronic, treatable conditions, it has become clear to the scientific community that the United States must recast its entire system of clinical research if such efforts are to remain as successful as they have been in the past. Over the years, clinical research has become more difficult to conduct. However, the exciting basic science discoveries currently being made demand that clinical research continue and even expand, while at the same time striving to improve efficiency and better inform basic science efforts. This is undoubtedly the most difficult but most important challenge identified by the NIH Roadmap process. At the core of this vision is the concept that clinical research needs to develop new partnerships among organized patient communities, community-based physicians and academic researchers. In the past, all research for a clinical trial could be conducted in one academic center; that is unlikely to be true in the future. In these initiatives, NIH will promote the creation of better integrated networks of academic centers that work jointly on clinical trials and that include community-based physicians who care for sufficiently large groups of well-characterized patients. Implementing this vision will require new ways to organize the way clinical research information is recorded, new standards for clinical research protocols, modern information technology, new models of cooperation between NIH and patient advocacy alliances and new strategies to re-energize the clinical research workforce.
2 Translational Research To improve human health, scientific discoveries must be translated into practical applications. Such discoveries typically begin at the bench with basic research where scientists study the mechanisms and pathogenesis of a disease at a molecular or cellular level then progress to the clinical level, or the patient s bedside. Scientists have become increasingly aware that this bench-to-bedside approach to translational research is really a two-way street. Not only do basic scientists deliver to clinicians new tools to examine in patients, clinical researchers also make novel observations about the nature and progression of disease that can stimulate basic investigations. Translational research has proven to be a powerful process that primes the entire clinical research engine. However, this component of the clinical research enterprise could be optimized and accelerated through a stronger infrastructure. Key to building a strong infrastructure will be to increase interactions between basic and clinical scientists, and ease the movement of powerful new tools from the laboratory into the clinic. In one approach aimed at accomplishing this, NIH is exploring development of regional translational research centers. These centers would provide sophisticated advice and resources to better enable scientists to master the many steps involved in bringing a new product from the bench to clinical use. Such steps involve laboratory studies to understand a therapy s mechanisms of action and animal studies to determine how well a therapeutic agent is absorbed into the body, how it is distributed to target tissues, how effective it is, and how likely it may be to cause unanticipated side effects. Once a potential new drug is developed, sufficient amounts of the drug have to be made according to rigorous standards for testing first in animals and then in people. The clinical research re-engineering initiative also envisions translational research core facilities to provide clinical researchers access to sophisticated manufacturing capacity, along with expert advice to ensure that drug-development regulations are observed. Some of these core facilities will be modeled on, or may evolve through expansion of, the National Cancer Institute s Rapid Access to Innovation Development (RAID) program, which currently provides these types of resources only to members of the cancer research community. Their availability to the broader research community should expedite discoveries for other major public health challenges. This initiative will also support translational research by developing new technologies to improve the assessment of clinical outcomes. Many of the most debilitating chronic illnesses gradually erode patients quality of life because of the associated fatigue, pain and mood changes. Currently, these critical symptoms cannot be objectively measured in the same way, for example, as blood sugar levels or blood cell counts. More sensitive, well-validated tools need to be developed to improve measurements of these types of symptoms. Technologies, such as a computerized adaptive health assessment, could revolutionize how symptoms and treatment outcomes are assessed. Scientists will be better equipped to understand how patients perceive changes in their health status resulting from new interventions, thereby directing research to therapies that would be most highly valued by patients.
3 Clinical Workforce Training Our nation s ability to fully explore the ever-expanding opportunities for medical advances are limited only by our resources, the most important of which is the scientific workforce. To fulfill the promise of 21 st century medicine and to make further progress in controlling major human diseases, we must cultivate and train a cadre of clinical researchers with skills commensurate with the increasing complexity and needs of the research enterprise. The clinical research workforce must be large enough to facilitate bench-to-bedside research, the phased testing of approaches from small to large studies and the translation of proven concepts into medical practice at the community level. Clinicians must be trained to work in the interdisciplinary, team-oriented environments that characterize today s emerging research efforts. Specific training is needed in an array of disciplines important to the conduct of clinical studies, including epidemiology, behavioral medicine and patient-oriented research. This NIH Roadmap effort envisions two major programs to expand, enhance and empower the clinical research workforce: the establishment of an agency-wide Multidisciplinary Clinical Research Workforce Training Program and a cadre of NIH Clinical Research Associates. The Multidisciplinary Clinical Research Workforce Training Program will be an NIHwide effort to train pre- and post-doctoral candidates in clinical research settings that are interdisciplinary and collaborative. The emphasis will be on new strategies and curricula with training opportunities that span a variety of disease areas; a broad range of clinical disciplines, including medicine, nursing, dentistry, pharmacy and other allied health professions; and a wide array of research areas, including biostatistics, behavioral medicine, clinical pharmacology and epidemiology. Generic training programs will be administered by a single institute on behalf of NIH, and programs focused on a specific disease or organ will be administered by the relevant institute. The new program will be coordinated with and complement other NIH training programs that support scholars who wish to become clinical researchers. In addition, a cadre of NIH Clinical Research Associates will be created. Composed of partnerships between academic and community-based investigators, this initiative will provide a robust and versatile infrastructure of qualified researchers who are well trained to ensure responsible conduct of clinical research and positioned to bring research opportunities to patients and rapidly disseminate the best science-based practices. Several projects will be required to realize the vision of the Associates. These include a study that will examine the feasibility of involving community practitioners in clinical research and explore possible mechanisms for such involvement. Building on the results of this study, recommendations on ways to reduce barriers to building a model workforce for conducting clinical research are expected to evolve. Other efforts will focus on the establishment of national core competencies and best practices needed to conduct high-quality clinical research and to translate research into clinical practice. These efforts will apply to researchers working in community or academic settings.
4 Competencies would include relevant board certification, knowledge of conflict-of-interest regulations and documentation of training in protecting participants in clinical trials. Best practices for research teams might include methods for managing study data, as well as developing cost and staffing estimates. To train the Associates, the NIH plans to create several nationally recognized regional Centers of Excellence in Clinical Research Training, based on the results of the feasibility and pilot studies. These centers will use an integrated approach to conduct training in real-world settings. Clinical Research Networks An enriched pipeline of biomedical discoveries, an infrastructure to facilitate their translation from the lab to the clinic and a robust force of clinical investigators will make it possible to test new therapeutic and preventive strategies in larger numbers of patients far sooner than at present. These large studies are often best conducted through networks of investigators who are equipped with tools to facilitate collaboration and information sharing. Because of the vast number of therapies, diagnostics and treatments that must be evaluated through clinical trials, many clinical research networks operate simultaneously, but independently of each other. As a result, researchers must sometimes duplicate already existing data because they are unaware the data exist or they cannot access them. Standardizing data reporting would enable seamless data and sample sharing across studies. In addition, by enhancing the efficiencies of clinical research networks through informatics and other technologies, researchers will be better able to broaden the scope of their research. Reduced duplication of studies will leave more time and funds to address additional research questions. This effort will promote and expand clinical research networks that can rapidly conduct high-quality clinical studies that address multiple research questions. An inventory of existing clinical research networks will explore existing informatics and training infrastructures to pinpoint characteristics that promote or inhibit successful network interactivity, productivity and expansion, or broadening of research scope. Best practices can then be identified and widely disseminated, further enhancing the efficiency of clinical research networks. Furthermore, a blueprint for a national informatics network using standardized data, software tools and network infrastructure will evolve from the inventory. The National Electronic Clinical Trials and Research Network (NECTAR) will dovetail with current medical informatics initiatives in the Department of Health and Human Services. It will maximize connectivity among existing and newly created clinical research networks. Researchers will be better equipped and more likely to generate and use data, thereby reducing duplicated efforts and unnecessary overlap between trials. Thus, NECTAR will ultimately assist in accelerating the pace of discovery and development, thereby helping clinical researchers better serve their patients. Other impediments to efficient clinical research to be addressed through this set of initiatives are the multiple requirements of diverse regulatory and policy agencies. Researchers face a tremendous diversity of requirements in reporting adverse events to NIH, the Food and
5 Drug Administration, the Office of Human Research Protections and institutional review boards, among others. Clinical researchers must understand and fulfill these varying requirements that often overlap and might even contradict one another. NIH aims to take a leadership role in working with other agencies to develop better processes and to standardize requirements for reporting adverse events, human subjects protections, privacy and conflict-of-interest policies and standards for electronic data submission. Harmonizing policies and reporting requirements will help minimize unnecessary burdens that slow research, while at the same time enhancing patient protections. For example, with extensive input, NIH has already designed a more efficient system for reporting adverse events unexpected or life-threatening problems that occur during a clinical trial. The system is being pilot tested by researchers doing gene therapy studies. Using the pilot system, clinical researchers can submit reports to all relevant oversight groups with a single keystroke, and the data can be analyzed and responded to promptly. By standardizing the regulatory requirements of clinical research networks and enhancing their interoperability, clinical research will advance more swiftly, and more and better therapies will reach patients nationwide. By creating a partnership with patients and physicians true communities of research this ambitious set of NIH Roadmap initiatives promises to enhance the scope, resilience, efficiency and impact of the nation s clinical research workforce, ultimately improving the health of all Americans. This information is available at the NIH Roadmap Web site ( For more information on the Re-Engineering the Clinical Research Enterprise initiatives, contact Bill Grigg in the NIH Office of the Director, (301) , # # #
Transforming the University of Wisconsin School of Medicine and Public Health January 2008
Transforming the University of Wisconsin School of Medicine and Public Health January 2008 A Compelling Case for Transformation Throughout most of the modern era of medicine there has been a lack of integration
exactly. The need for efficiency in developing effective new therapeutics has never been greater.
exactly. The need for efficiency in developing effective new therapeutics has never been greater. As demands on the global healthcare system increase and treating disease becomes more complex, the research,
Northeast Ohio Medical University (NEOMED) Chair of Pharmaceutical Sciences Search
Northeast Ohio Medical University (NEOMED) Chair of Pharmaceutical Sciences Search Spring 2013 About NEOMED Northeast Ohio Medical University (NEOMED) www.neomed.edu is a dynamic free-standing community-based,
How To Change Medicine
P4 Medicine: Personalized, Predictive, Preventive, Participatory A Change of View that Changes Everything Leroy E. Hood Institute for Systems Biology David J. Galas Battelle Memorial Institute Version
Draft NIEHS Strategic Plan. Mission, Vision, Strategic Pillars, Strategic Goals. Draft Mission Statement
Draft NIEHS Strategic Plan Mission, Vision, Strategic Pillars, Strategic Goals Draft Mission Statement The mission of the National Institute of Environmental Health Sciences is to discover how the environment
UMKC STRATEGIC PLAN LIFE AND HEALTH SCIENCES 1. IMPLEMENT ORGANIZATIONAL ENHANCEMENTS TO ADVANCE THE
UMKC STRATEGIC PLAN LIFE AND HEALTH SCIENCES OBJECTIVES: 1. IMPLEMENT ORGANIZATIONAL ENHANCEMENTS TO ADVANCE THE LIFE AND HEALTH SCIENCES Recruit a Vice Chancellor for Life and Health Sciences Research
Academic Health Center Six-Year Strategic Plan October 20, 2000
Goal 1: Create and Prepare the New Health Professionals for Minnesota Strategic Objectives 1.0 Develop and implement interdisciplinary health professional education opportunities that: Emphasize the core
Vision for the Cohort and the Precision Medicine Initiative Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health Precision
Vision for the Cohort and the Precision Medicine Initiative Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health Precision Medicine Initiative: Building a Large U.S. Research Cohort
Graduate Program Objective #1 Course Objectives
1 Graduate Program Objective #1: Integrate nursing science and theory, biophysical, psychosocial, ethical, analytical, and organizational science as the foundation for the highest level of nursing practice.
March 17, 2011. Re: Feedback on the NINR Draft Strategic Plan 2011
March 17, 2011 Patricia A. Grady, PhD, RN, FAAN Director National Institute of Nursing Research National Institutes of Health 31 Center Drive, Room 5B10 Bethesda, Maryland 20892-2178 Sent Via email to:
American College of Medical Genetics and Genomics Strategic Plan
American College of Medical Genetics and Genomics Strategic Plan The American College of Medical Genetics and Genomics (ACMG) is the specialty society for diplomates certified by the American Board of
Graduate and Postdoctoral Affairs School of Biomedical Sciences College of Medicine. Graduate Certificate. Metabolic & Nutritional Medicine
Graduate and Postdoctoral Affairs School of Biomedical Sciences College of Medicine Graduate Certificate in Metabolic & Nutritional Medicine Graduate Certificate Metabolic & Nutritional Medicine Purpose
Vision 2020 Strategic Plan
UNIVERSITY OF HOUSTON COLLEGE OF PHARMACY Vision 2020 Strategic Plan A VISION OF THE FUTURE Caring for Texans through health and discovery The college will be a leader in education, research, service and
Office of Clinical Research and the. Institute (CTSI) Patricia Emmanuel, MD
Office of Clinical Research and the Clinical and Translational Research Institute (CTSI) Patricia Emmanuel, MD Office of Clinical Research- Priorities Review processes for clinical study implementation,
Vanderbilt University Biomedical Informatics Graduate Program (VU-BMIP) Proposal Executive Summary
Vanderbilt University Biomedical Informatics Graduate Program (VU-BMIP) Proposal Executive Summary Unique among academic health centers, Vanderbilt University Medical Center entrusts its Informatics Center
Evaluation Process and Performance Measurement in Health Care
Cancer Center of Excellence Performance Measures, Rating System, and Rating Standard 1 Introduction The designation of a hospital, treatment center, or other organization as a Cancer Center of Excellence
APPENDIX C: ACADEMIC MISSION STATEMENT
APPENDICES APPENDIX C: ACADEMIC MISSION STATEMENT The University of California, San Francisco shares the University s mission of achieving excellence in education, research, and public service. As a graduate
Excerpt from: The Future of Nursing: Leading Change, Advancing Health http://www.nap.edu/catalog.php?record_id=12956
Excerpt from: The Future of Nursing: Leading Change, Advancing Health http://www.nap.edu/catalog.php?record_id=12956 THE ROLE OF NURSES IN REALIZING A TRANSFORMED HEALTH CARE SYSTEM By virtue of its numbers
Kentucky Lung Cancer Research Program. 2010 Strategic Plan Update
Kentucky Lung Cancer Research Program 2010 Strategic Plan Update Approved by the KLCR Program Governance Board August 12, 2009 KLCR Program Strategic Plan Table of Contents Introduction... 3 GOAL 1: Investigator-Initiated
FEDERAL PAIN PORTFOLIO PREVIEW
FEDERAL PAIN PORTFOLIO PREVIEW Federal Agencies: AHRQ, CDC, DoD, FDA, NIH, VA Interagency Pain Research Coordinating Committee March 27, 2012 IPRCC Charge I. Develop a summary of advances in pain care
National Institute of Nursing Research s. ReseaRch TRaining grants and opportunities
National Institute of Nursing Research s ReseaRch TRaining grants and opportunities overview of ninr The National Institute of Nursing Research (NINR), a component of the National Institutes of Health
Morehouse School of Medicine
Morehouse School of Medicine Strategic Plan March 2015 1 STRATEGIC FRAMEWORK Mission, Vision, Core Values, Goals 2 Strategic Structure Each Statement Lays the Foundation for the Next Vision Vision Goals
National Nursing Informatics Deep Dive Program
National Nursing Informatics Deep Dive Program What is Nursing Informatics and Why is it Important? Connie White Delaney, PhD, RN, FAAN, FACMI Dean and Professor, School of Nursing Director, Clinical and
Academic health centers play an essential
of Current Ryan D. Brutger, MA Together, academic and community health centers can treat patients, perform research, and expand clinical trials in ways that neither would be able to do on their own. Academic
CCH III. Domestic regulations for recruiting and retaining CSME. implemented in Member States by 2011
CCH III REGIONAL PROGRAMME AREA: HUMAN RESOURCE DEVELOPMENT GOAL: Human resources within the sector developed to respond to the needs of the people PRIORITIES OBJECTIVES NATIONAL EXPECTED RESULTS Movement
Fiscal Year 2013 (FY13) Prostate Cancer Research Program (PCRP) Reference Table of Award Mechanisms and Submission Requirements
Fiscal Year 2013 (FY13) Prostate Cancer Research Program (PCRP) Reference Table of Award Mechanisms and Submission Requirements PCRP AWARD MECHANISMS WITH EMPHASIS ON RESOURCES Clinical Consortium Award
646 HEALTH CARE POLICY IN THE U.S.: DEVELOPMENT, IMPACTS AND IMPLICATIONS FOR NURSES
Graduate Courses: Master s Courses (NURS) AY 2012-13 (Effective August 2012) Professional Core 646 HEALTH CARE POLICY IN THE U.S.: DEVELOPMENT, IMPACTS AND IMPLICATIONS FOR NURSES (3). This course examines
The. for DUKE MEDICINE. Duke University School of Medicine. People
The for DUKE MEDICINE Decades of hard work by dedicated physicians and scientists, along with capable and often inspired leadership, have placed the Duke School of Medicine among the nation s best. Now,
Clinical Trials. In Singapore. Clinical Trials in Asia Pacifi c. Introduction. Healthcare Clusters. www.asiabiotech.com
Clinical Trials In Singapore Dr Say-Beng Tan, Dr Eugene Fidelis Soh, and Dr Han-Chong Toh Introduction Clinical trials are the gold standard for the evaluation of new treatment strategies. New treatments
2019 Healthcare That Works for All
2019 Healthcare That Works for All This paper is one of a series describing what a decade of successful change in healthcare could look like in 2019. Each paper focuses on one aspect of healthcare. To
One Research Court, Suite 200 Rockville, MD 20850 www.ctisinc.com Tel: 301.948.3033 Fax: 301.948.2242
TRANSFORMATION OF HEALTH INDUSTRY THROUGH PERFORMANCE PYRAMID: Providing Excellent End-to-End Healthcare to the Population with a 30% Reduction in Cost and Time. Introduction The American health industry
Department of Behavioral Sciences and Health Education
ROLLINS SCHOOL OF PUBLIC HEALTH OF EMORY UNIVERSITY Core Competencies Upon graduation, a student with an MPH/MSPH should be able to: Use analytic reasoning and quantitative methods to address questions
SACKLER SCHOOL OF GRADUATE BIOMEDICAL SCIENCES CATALOG 2015-2016 PROGRAMS OF STUDY, COURSES AND REQUIREMENTS FOR ALL GRADUATE PROGRAMS
SACKLER SCHOOL OF GRADUATE BIOMEDICAL SCIENCES CATALOG 2015-2016 PROGRAMS OF STUDY, COURSES AND REQUIREMENTS FOR ALL GRADUATE PROGRAMS Graduate Programs CELL, MOLECULAR, AND DEVELOPMENTAL BIOLOGY CLINICAL
CLINICAL TRIALS SHOULD YOU PARTICIPATE? by Gwen L. Nichols, MD
CLINICAL TRIALS SHOULD YOU PARTICIPATE? by Gwen L. Nichols, MD Gwen L. Nichols, M.D., is currently the Oncology Site Head of the Roche Translational Clinical Research Center at Hoffman- LaRoche. In this
U.S. Food and Drug Administration Center for Devices and Radiological Health REGULATORY SCIENCE PRIORITIES (FY2016)
U.S. Food and Drug Administration Center for Devices and Radiological Health REGULATORY SCIENCE PRIORITIES (FY2016) Executive Summary October 20, 2015 The Regulatory Science Subcommittee (RSS) of the CDRH
UCSF Clinical Enterprise Strategic Plan 2014-2019
UCSF HEALTH SYSTEM UCSF Clinical Enterprise Strategic Plan 2014-2019 Building the Health System 1 UCSF Health System Five Year Strategic Plan: FY 2014-2019 Advancing the Health System A revolution is underway
Purpose. Admission Requirements NURSING EDUCATION STUDENT LEARNING OUTCOMES RESIDENCY REQUIREMENTS. Clinical Requirements
NURSING EDUCATION Purpose This program is designed for professional nurses who have earned a Master s or Doctoral Degree in Nursing and seek further education in advanced nursing practice. Concentrations
Nurse Researcher or Clinical Research Nurse: Understanding the Difference
Nurse Researcher or Clinical Research Nurse: Understanding the Difference Claudia D. Smith, PhD, RN, NE-BC Director, Nursing Research St. Luke s Medical Center An Alternate Title for the Presentation:
2011-2016 Strategic Plan. Creating a healthier world through bold innovation
2011-2016 Strategic Plan Creating a healthier world through bold innovation 2011-2016 STRATEGIC PLAN Table of contents I. Global direction 1 Mission and vision statements 2 Guiding principles 3 Organizational
Executive Search Announcement
Executive Search Announcement i n v i t e s a p p l i c a t i o n s a n d n o m i n a t i o n s f o r Assistant Dean for Research for the School of Nursing and School of Health Professions The University
Masters of Science in Clinical Research (MSCR) Curriculum. Goal/Objective of the MSCR
Masters of Science in Clinical (MSCR) Curriculum Goal/Objective of the MSCR The MSCR program is an interdisciplinary research degree program housed within the Department of Epidemiology in the School of
Nurse Practitioner Student Learning Outcomes
ADULT-GERONTOLOGY PRIMARY CARE NURSE PRACTITIONER Nurse Practitioner Student Learning Outcomes Students in the Nurse Practitioner Program at Wilkes University will: 1. Synthesize theoretical, scientific,
1900 K St. NW Washington, DC 20006 c/o McKenna Long
1900 K St. NW Washington, DC 20006 c/o McKenna Long Centers for Medicare & Medicaid Services U. S. Department of Health and Human Services Attention CMS 1345 P P.O. Box 8013, Baltimore, MD 21244 8013 Re:
Top Ten Things to Know About Stem Cell Treatments
Top Ten Things to Know About Stem Cell Treatments Many clinics that are offering stem cell treatments make claims about what stem cells can and cannot do that are not supported by our understanding of
What does the AHSC mean for you?
> > > > > > > > > > > > > > > > > > > > What does the AHSC mean for you? Our vision for the UK s first Academic Health Science Centre a mini-guide for patients Quicker access to new medicines and new treatments
Clinical and Translational Science: a role for libraries
Clinical and Translational Science: a role for libraries Presented at the Science Translational Medicine Luncheon Special Libraries Association 2010 Annual Conference New Orleans, LA, on 15 June 2010.
Obtaining Funding in Clinical Research
Obtaining Funding in Clinical Research Ellen Seely, MD Director of Clinical Research Endocrinology, Diabetes and Hypertension Division Vice Chair, Faculty Development, Department of Medicine Brigham and
SOUTHERN UNIVERSITY AND A&M COLLEGE BATON ROUGE, LOUISIANA
MASTER OF SCIENCE IN NURSING (MSN) COURSE DESCRIPTIONS 600. THEORETICAL FOUNDATIONS OF ADVANCED NURSING (Credit, 3 hours). A systematic examination of the concepts of nursing, human beings, health, and
CLINICAL AND TRANSLATIONAL SCIENCES, DOCTOR OF PHILOSOPHY (PH.D.) WITH A CONCENTRATION IN CANCER AND MOLECULAR MEDICINE
VCU 1 CLINICAL AND TRANSLATIONAL SCIENCES, DOCTOR OF PHILOSOPHY (PH.D.) WITH A CONCENTRATION IN CANCER AND MOLECULAR MEDICINE Program goal The doctoral program in clinical and translational sciences offers
Clinical Trials: The Crux of Cancer Innovation
Clinical Trials: The Crux of Cancer Innovation Even as medical science is transforming cancer care, major deficiencies in the way cancer clinical trials are designed, carried out, regulated and funded
Post-Doctoral Pharmaceutical Industry Fellowships. Two-Year Clinical Development Program Two-Year Clinical Safety Program
Post-Doctoral Pharmaceutical Industry Fellowships Two-Year Clinical Development Program Two-Year Clinical Safety Program Today, we innovate by creating new medicines, as well as new methods of drug discovery
A leader in the development and application of information technology to prevent and treat disease.
A leader in the development and application of information technology to prevent and treat disease. About MOLECULAR HEALTH Molecular Health was founded in 2004 with the vision of changing healthcare. Today
Targeting Cancer: Innovation in the Treatment of Chronic Myelogenous Leukemia EXECUTIVE SUMMARY. New England Healthcare Institute
Targeting Cancer: Innovation in the Treatment of Chronic Myelogenous Leukemia New England Healthcare Institute NEHI Innovation Series March 2004 Executive Summary From drugs and medical devices, to information
UNCLASSIFIED STATEMENT BY
UNCLASSIFIED FINAL STATEMENT BY CAROLYN J.M. BEST, PhD PROGRAM MANAGER OF THE PROSTATE CANCER RESEARCH PROGRAM OF THE CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS OF THE UNITED STATES ARMY MEDICAL
Project HealthDesign:
E-Primer 1 Project HealthDesign: Rethinking the Power and Potential of Personal Health Records A New Vision for Personal Health Records Health care institutions and software developers currently offer
RN-MS Program. Purpose. Admission Requirements. State Requirements for Online/Distance Education. Degree Requirements
RN-MS PROGRAM RN-MS Program Purpose This accelerated program is designed for the experienced, practicing registered nurse who plans to continue nursing studies through the master's level and does not hold
How To Improve Health Information Technology
The American Society For Clinical Pathology Policy Statement Health Information Technology/Informatics (Policy Number) Policy Statement: ASCP supports the implementation of standardized health information
The University of Texas Health Science Center at San Antonio Tobacco Funds Budget Fiscal Year Ending August 31, 2015
Permanent Health Funds for Higher Education (Fund 810) Permanent Health Funds will be assigned to schools to support health education, research programs, and infrastructure operations. Strategy F.1.2.,
TransCelerate's Role in Transforming Pharmaceutical Trials Presentation to PCORNet
TransCelerate's Role in Transforming Pharmaceutical Trials Presentation to PCORNet Dalvir Gill, PhD - Chief Executive Officer 17 October, 2014 Presentation Objectives + TransCelerate History + Participating
Issues. Does the academe have as a goal or an obligation, the development of its discoveries for human benefit?
ELLEN PURÉ, Ph.D. Issues Does the academe have as a goal or an obligation, the development of its discoveries for human benefit? Can the academic review process support individual career development in
The Evolving Role of Nurses in Early Phase Research
U.S. Department of Health and Human Services The Evolving Role of Nurses in Early Phase Research Clare Hastings, RN, PhD, FAAN Chief Nurse Officer, Clinical Center April 27, 2012 Discover America s Research
Post Graduate/APRN Certificate Programs
POST-GRADUATE CERTIFICATE Post Graduate/APRN Certificate Programs Purpose This distance education program is designed for the experienced registered nurse who has earned a master s or doctoral degree in
TABLE OF CONTENTS. Introduction...1. Chapter1 AdvancesinTreatment...2. Chapter2 MedicinesinDevelopment...11. Chapter3 ValueandSpending...
CANCER TABLE OF CONTENTS Introduction...1 Chapter1 AdvancesinTreatment...2 Chapter2 MedicinesinDevelopment......11 Chapter3 ValueandSpending......15 Chapter4 Conclusion...22 INTRODUCTION Researchers and
NIH Commons Overview, Framework & Pilots - Version 1. The NIH Commons
The NIH Commons Summary The Commons is a shared virtual space where scientists can work with the digital objects of biomedical research, i.e. it is a system that will allow investigators to find, manage,
PART I. SECTION 1. The legislature finds that an estimated. 128,000,000 Americans suffer from the crippling economic and
HOUSE OF REPRESENTATIVES TWENTY-FOURTH LEGISLATURE, 2007 STATE OF HAWAII A BILL FOR AN ACT RELATING TO MEDICAL RESEARCH. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII: PART I SECTION 1. The legislature
Goal 1; Objective B: Improve health care quality and patient safety: Performance measure
TRUST FOR AMERICA S HEALTH COMMENTS ON THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) DRAFT STRATEGIC PLAN 2010 2015 Goal 1; Objective B: Improve health care quality and patient safety: Performance
HOT TOPICS IN IN HEALTH CARE REFORM
By Felicia Fuller Publications Manager, DAC Patient Recruitment Services The Patient Protection and Affordable Care Act (ACA), colloquially known as Obamacare, is in full effect and its impact is palpable
The MSCR Curriculum and Its Advantages
Masters of Science in Clinical Research (MSCR) Curriculum Goal/Objective of the MSCR The MSCR program is an interdisciplinary research degree program housed within the Department of Epidemiology in the
Diagnostic Tests. Brad Spring Director, Regulatory Affairs
Regulatory Challenges in the Development of Diagnostic Tests Industry Perspective Brad Spring Director, Regulatory Affairs September 28, 2011 Balancing Evidence of Safety & Effectiveness and Time to Market
PROGRAMS OF STUDY BETTY IRENE MOORE SCHOOL OF NURSING AT UC DAVIS. 130 Betty Irene Moore School of Nursing
BETTY IRENE MOORE SCHOOL OF NURSING 130 Betty Irene Moore School of Nursing BETTY IRENE MOORE SCHOOL OF NURSING AT UC DAVIS Education Building, Sacramento campus UC Davis Health System 916-734-2145; http://nursing.ucdavis.edu
SELECTED PROJECTS: HEALTH INFORMATION TECHNOLOGY
SELECTED PROJECTS: HEALTH INFORMATION TECHNOLOGY Personal Health Information Management and the Design of Consumer Health Information Technology Client: U.S. Department of Health and Human Services, Agency
Principles on Health Care Reform
American Heart Association Principles on Health Care Reform The American Heart Association has a longstanding commitment to approaching health care reform from the patient s perspective. This focus including
How To Become A Hospital Epidemiologist
Program Description for students entering graduate program prior to January 2008 MSc with specialization in Hospital Epidemiology Offered by the Departments of Community Health Sciences and Microbiology/Infectious
Implementing the National Pain Strategy in an Era of Accountable Care: Improving Chronic Pain Care in America. Request for Proposals (RFP)
Implementing the National Pain Strategy in an Era of Accountable Care: Improving Chronic Pain Care in America Request for Proposals (RFP) The American Pain Society and Pfizer Independent Grants for Learning
Formulary Management
Formulary Management Formulary management is an integrated patient care process which enables physicians, pharmacists and other health care professionals to work together to promote clinically sound, cost-effective
K.G. Jebsen centers for Translational Medical Research. Call 2016
Thormøhlensgt. 51 N-5006 BERGEN, Norway Tel. +47908 57 399 Org. No: 993 962 724 www.stiftkgj.no K.G. Jebsen centers for Translational Medical Research Call 2016 Stiftelsen Kristian Gerhard Jebsen (SKGJ)
Regulatory and Legislative Action Since the September 2010 Membership Meeting:
MEMBERSHIP MEETING January 19, 2011 Delivery System Reform: Healthcare Workforce Issue: The passage of health reform will bring millions of newly insured individuals into the system and drive patients
NIH MENTORED CAREER DEVELOPMENT AWARDS (K01, K08, K23)
NIH MENTORED CAREER DEVELOPMENT AWARDS (K01, K08, K23) Note: the information below is extracted from the current Program Announcements; before applying for a K award you should obtain and read the most
May 17, 2015. Office of Extramural Research National Institutes of Health 9000 Rockville Pike Bethesda, Maryland 20892
Office of Extramural Research National Institutes of Health 9000 Rockville Pike Bethesda, Maryland 20892 RE: Request for Information (RFI): Optimizing Funding Policies and Other Strategies to Improve the
The mission of the Graduate College is embodied in the following three components.
Action Plan for the Graduate College Feb. 2012 Western Michigan University Introduction The working premises of this plan are that graduate education at WMU is integral to the identity and mission of the
Components of Geonomics and Bio-Informatics
Components of Geonomics and Bio-Informatics Shankar Srinivasan, PhD Department of Health Informatics University of Medicine and Dentistry of New Jersey Newark, New Jersey World Health Organization (WHO)
International Society of Exposure Science (ISES) Strategic Plan: Creating a Safer and Healthier World by Advancing The Science of Exposure 2008 2011
International Society of Exposure Science (ISES) Strategic Plan: Creating a Safer and Healthier World by Advancing The Science of Exposure 2008 2011 Executive Summary Changes in the field of exposure have
Department of Interdisciplinary Studies Bachelor's, Master's and Ph.D. Programs Online All the Time A Year of Growth and New Initiatives
Department of Interdisciplinary Studies Bachelor's, Master's and Ph.D. Programs Online All the Time A Year of Growth and New Initiatives The Department of Interdisciplinary Studies continues to excel in
National Cancer Institute
National Cancer Institute Taking Part in Cancer Treatment Research Studies U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Taking Part in Cancer Treatment Research Studies If
International Stem Cell Registry
International Stem Cell Registry Importance of Stem Cells Stem cells are model systems for the study of development and disease. Pluripotent stem cells offer new tools for drug design and discovery. Pluripotent
Exploratory Brief on Nanomedicine or the Application of Nanotechnology in Human Healthcare
Exploratory Brief on Nanomedicine or the Application of Nanotechnology in Human Healthcare Paula Corabian, Dagmara Chojecki March 6, 2012 Objectives Provincial Health Technology Assessment (HTA) Program
Doctor of Nursing Practice (DNP)
DOCTOR OF NURSING PRACTICE (DNP) Doctor of Nursing Practice (DNP) Purpose The distance education program leading to the Doctor of Nursing Practice degree at Wilkes University is linked to the mission statements
Patient Handbook on Stem Cell Therapies
Patient Handbook on Stem Cell Therapies Appendix I of the Guidelines for the Clinical Translation of Stem Cells www.isscr.org 2008, International Society for Stem Cell Research 2 Introduction We have all
Florida A&M University Revised New Degree Programs for Strategic Plan (Revision approved June 2013) 2010-2020
Florida A&M University Revised New Degree Programs for Strategic Plan (Revision approved June 2013) 2010-2020 Appendix B CIP Code School of Business and Industry 52.0801 BS Finance 52.1401 BS Marketing
Human Health Sciences
Human Health Sciences WITH PLYMOUTH UNIVERSITY DISCOVER MORE If you would like to visit Plymouth and meet our staff, then why not come along to one of our open days. Human Health Sciences WITH PLYMOUTH
Comments on the 21 st Century Cures: Digital Health Care
Comments on the 21 st Century Cures: Digital Health Care July 22, 2014 The Pharmaceutical Research and Manufacturers of America (PhRMA) appreciates the opportunity to provide input to the House Energy
Public Health Research - A Case Study in Innovation
Global trends in health research and innovation policy Jonathan Grant Oslo, January 2014 RAND Europe is an independent not-forprofit public policy research institute Not a university or management consultancy
The Doctorate in Clinical Laboratory Science in USA
The Doctorate in Clinical Laboratory Science in USA Dr. Behzad Poopak, DCLS PhD. Head Iranian Association of Clinical Laboratory Doctors bpoopak@gmail.com Important Work! Clinical laboratory professionals
Ask Us About Clinical Trials
Ask Us About Clinical Trials Clinical Trials and You. Our specialists and researchers are at the forefront of their fields and are leading the way in developing new therapies and procedures for diagnosing
Introduction and Invitation for Public Comment
2 of 22 Introduction and Invitation for Public Comment The Patient-Centered Outcomes Research Institute (PCORI) is an independent, non-profit health research organization. Its mission is to fund research
Cancer Services for Adults and Children
UCSF HEALTH Cancer Services for Adults and Children Our world-class clinical and research programs are engaged in the urgent effort to cure cancers and, where cures currently elude us, transform cancer
The Future of Census Bureau Operations
The Future of Census Bureau Operations Version 1.0 April 25, 2013 The Future of Census Bureau Operations Page ii [This page intentionally left blank] The Future of Census Bureau Operations Page iii Document
THE SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER AT JOHNS HOPKINS
Ushering in a new era of cancer medicine Center is ushering in a new era of cancer medicine. Progress that could not even be imagined a decade ago is now being realized in our laboratories and our clinics.
Course Descriptions NUR 3805 Nursing Roles, Dimensions and Perspectives 3 credits NUR 3069 Advanced Health Assessment 2 credits
Course Descriptions NUR 3805 Nursing Roles, Dimensions and Perspectives 3 credits The discipline of Nursing has been identified as having the potential for making a major impact on the transformation of
EXECUTIVE SUMMARY Prepared for: Pharmaceutical Research and Manufacturers of America (PhRMA) Prepared by: Battelle Technology Partnership Practice
EXECUTIVE SUMMARY Prepared for: Pharmaceutical Research and Manufacturers of America (PhRMA) Prepared by: Battelle Technology Partnership Practice Battelle is the world s largest non profit independent